1503 related articles for article (PubMed ID: 22442263)
1. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).
Gagnon C; Lu ZX; Magliano DJ; Dunstan DW; Shaw JE; Zimmet PZ; Sikaris K; Ebeling PR; Daly RM
J Clin Endocrinol Metab; 2012 Jun; 97(6):1953-61. PubMed ID: 22442263
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women.
Schmitt EB; Nahas-Neto J; Bueloni-Dias F; Poloni PF; Orsatti CL; Petri Nahas EA
Maturitas; 2018 Jan; 107():97-102. PubMed ID: 29169589
[TBL] [Abstract][Full Text] [Related]
3. Associations of serum 25-hydroxyvitamin D with metabolic syndrome and its components in elderly men and women: the Korean Urban Rural Elderly cohort study.
Lee SJ; Lee EY; Lee JH; Kim JE; Kim KJ; Rhee Y; Kim HC; Youm Y; Kim CO
BMC Geriatr; 2019 Apr; 19(1):102. PubMed ID: 30975093
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D and metabolic syndrome in a Japanese working population: The Furukawa Nutrition and Health Study.
Akter S; Eguchi M; Kurotani K; Kochi T; Kashino I; Ito R; Kuwahara K; Tsuruoka H; Kabe I; Mizoue T
Nutrition; 2017 Apr; 36():26-32. PubMed ID: 28336104
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Status of Residents in Taiyuan, China and Influencing Factors.
Yan X; Thomson JS; Zhao R; Zhu R; Wang Z; Zhang N; Coad J
Nutrients; 2017 Aug; 9(8):. PubMed ID: 28820448
[TBL] [Abstract][Full Text] [Related]
6. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components.
Kayaniyil S; Vieth R; Harris SB; Retnakaran R; Knight JA; Gerstein HC; Perkins BA; Zinman B; Hanley AJ
J Clin Endocrinol Metab; 2011 Jan; 96(1):168-75. PubMed ID: 20980431
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D status and metabolic syndrome in the elderly: the Rotterdam Study.
Vitezova A; Zillikens MC; van Herpt TT; Sijbrands EJ; Hofman A; Uitterlinden AG; Franco OH; Kiefte-de Jong JC
Eur J Endocrinol; 2015 Mar; 172(3):327-35. PubMed ID: 25468955
[TBL] [Abstract][Full Text] [Related]
8. Prospective association of 25(OH)D with metabolic syndrome.
Kayaniyil S; Harris SB; Retnakaran R; Vieth R; Knight JA; Gerstein HC; Perkins BA; Zinman B; Hanley AJ
Clin Endocrinol (Oxf); 2014 Apr; 80(4):502-7. PubMed ID: 23452164
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Deficiency in Relation to the Risk of Metabolic Syndrome in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus.
Pan GT; Guo JF; Mei SL; Zhang MX; Hu ZY; Zhong CK; Zeng CY; Liu XH; Ma QH; Li BY; Qin LQ; Zhang ZL
J Nutr Sci Vitaminol (Tokyo); 2016; 62(4):213-219. PubMed ID: 27725405
[TBL] [Abstract][Full Text] [Related]
10. Low socio-economic status is a newly identified independent risk factor for poor vitamin D status in severely obese adults.
Léger-Guist'hau J; Domingues-Faria C; Miolanne M; Peyrol F; Gerbaud L; Perreira B; Minet-Quinard R; Sapin V; Walrand S; Boirie Y
J Hum Nutr Diet; 2017 Apr; 30(2):203-215. PubMed ID: 27524803
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D status and its relationship with metabolic syndrome risk factors among adolescent girls in Boukan, Iran.
Rafraf M; Hasanabad SK; Jafarabadi MA
Public Health Nutr; 2014 Apr; 17(4):803-9. PubMed ID: 24477119
[TBL] [Abstract][Full Text] [Related]
12. Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001-2010.
Al-Khalidi B; Kimball SM; Rotondi MA; Ardern CI
Nutr J; 2017 Feb; 16(1):16. PubMed ID: 28241878
[TBL] [Abstract][Full Text] [Related]
13. Serum 25-hydroxyvitamin D levels, obesity and the metabolic syndrome among Korean children.
Lee SH; Kim SM; Park HS; Choi KM; Cho GJ; Ko BJ; Kim JH
Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):785-91. PubMed ID: 22762845
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between vitamin D deficiency and metabolic syndrome].
González-Molero I; Rojo G; Morcillo S; Pérez-Valero V; Rubio-Martín E; Gutierrez-Repiso C; Soriguer F
Med Clin (Barc); 2014 Jun; 142(11):473-7. PubMed ID: 24216018
[TBL] [Abstract][Full Text] [Related]
15. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study).
Gagnon C; Lu ZX; Magliano DJ; Dunstan DW; Shaw JE; Zimmet PZ; Sikaris K; Grantham N; Ebeling PR; Daly RM
Diabetes Care; 2011 May; 34(5):1133-8. PubMed ID: 21430082
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD.
Damasiewicz MJ; Magliano DJ; Daly RM; Gagnon C; Lu ZX; Sikaris KA; Ebeling PR; Chadban SJ; Atkins RC; Kerr PG; Shaw JE; Polkinghorne KR
Am J Kidney Dis; 2013 Jul; 62(1):58-66. PubMed ID: 23623574
[TBL] [Abstract][Full Text] [Related]
17. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome.
Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA
Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853
[TBL] [Abstract][Full Text] [Related]
18. Serum 25(OH)D and incident type 2 diabetes: a cohort study.
Husemoen LL; Skaaby T; Thuesen BH; Jørgensen T; Fenger RV; Linneberg A
Eur J Clin Nutr; 2012 Dec; 66(12):1309-14. PubMed ID: 23031851
[TBL] [Abstract][Full Text] [Related]
19. Serum 25(OH)D and adipokines levels in people with abdominal obesity.
Karonova T; Belyaeva O; Jude EB; Tsiberkin A; Andreeva A; Grineva E; Pludowski P
J Steroid Biochem Mol Biol; 2018 Jan; 175():170-176. PubMed ID: 27629594
[TBL] [Abstract][Full Text] [Related]
20. Relationship between deficiency of vitamin D and exponents of metabolic syndrome.
Kramkowska M; Grzelak T; Walczak M; Bogdanski P; Pupek-Musialik D; Czyzewska K
Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2180-7. PubMed ID: 26166640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
